List of Contents

Parenteral Nutrition Market Size, Share, and Trends 2024 to 2034

The global parenteral nutrition market size is calculated at USD 7.22 billion in 2024, grew to USD 7.67 billion in 2025, and is predicted to hit around USD 13.17 billion by 2034, poised to grow at a CAGR of 6.2% between 2024 and 2034. The North America parenteral nutrition market size accounted for USD 2.96 billion in 2024 and is anticipated to grow at the fastest CAGR of 6.33% during the forecast year.

  • Last Updated : October 2024
  • Report Code : 3417
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Parenteral Nutrition Market 

5.1. COVID-19 Landscape: Parenteral Nutrition Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Parenteral Nutrition Market, By Nutrient Type

8.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Nutrient Type, 2024-2034

8.1.1. Carbohydrates

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Parenteral Lipid Emulsion

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Single Dose Amino Acid Solution

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

8.1.4. Trace Elements

8.1.4.1. Market Revenue and Volume Forecast (2021-2034)

8.1.5. Vitamins & Minerals

8.1.5.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Parenteral Nutrition Market, By Stage Type

9.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Stage Type, 2024-2034

9.1.1. Adult

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Pediatrics

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Parenteral Nutrition Market, By Indication 

10.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Indication, 2024-2034

10.1.1. Alzheimer’s

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Nutrition Deficiency

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Cancer Care

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

10.1.4. Chronic Kidney Diseases

10.1.4.1. Market Revenue and Volume Forecast (2021-2034)

10.1.5. Orphan Diseases

10.1.5.1. Market Revenue and Volume Forecast (2021-2034)

10.1.6. Dysphagia

10.1.6.1. Market Revenue and Volume Forecast (2021-2034)

10.1.7. Pain Management

10.1.7.1. Market Revenue and Volume Forecast (2021-2034)

10.1.8. Malabsorption/GI Disorder/Diarrhea

10.1.8.1. Market Revenue and Volume Forecast (2021-2034)

10.1.9. Others

10.1.9.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Parenteral Nutrition Market, By Sales Channel 

11.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Sales Channel, 2024-2034

11.1.1. Online Sales

11.1.1.1. Market Revenue and Volume Forecast (2021-2034)

11.1.2. Retail Sales

11.1.2.1. Market Revenue and Volume Forecast (2021-2034)

11.1.3. Institutional Sales

11.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 12. Global Parenteral Nutrition Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.1.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.1.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.1.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.1.5.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.1.5.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.1.5.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.1.6.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.1.6.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.1.6.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.2.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.2.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.2.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.2.5.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.2.5.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.2.5.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.2.6.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.2.6.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.2.6.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.2.7.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.2.7.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.2.7.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.2.8.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.2.8.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.2.8.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.3.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.3.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.3.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.3.5.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.3.5.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.3.5.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.3.6.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.3.6.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.3.6.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.3.7.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.3.7.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.3.7.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.3.8.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.3.8.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.3.8.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.4.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.4.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.4.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.4.5.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.4.5.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.4.5.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.4.6.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.4.6.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.4.6.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.4.7.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.4.7.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.4.7.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.4.8.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.4.8.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.4.8.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.5.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.5.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.5.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.5.5.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.5.5.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.5.5.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2021-2034)

12.5.6.2. Market Revenue and Volume Forecast, by Stage Type (2021-2034)

12.5.6.3. Market Revenue and Volume Forecast, by Indication (2021-2034)

12.5.6.4. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)

Chapter 13. Company Profiles

13.1. Baxter

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Allergan

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Actavis Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Otsuka Pharmaceutical Factory, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Grifols, S.A.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. B. Braun Melsungen AG

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Vifor Pharma

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Fresenius Kabi AG

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Sichuan Kelun Pharmaceutical Co., Ltd.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Pfizer Inc. (Hospira Inc.)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client